# The Study of the Impact of Disclosing Imaging Study Information to Trial Participants

> **NCT00354003** · — · COMPLETED · sponsor: **Institute for Neurodegenerative Disorders** · enrollment: 800 (estimated)

## Conditions studied

- Parkinsonian Syndrome
- Parkinson

## Interventions

- **BEHAVIORAL:** A series of questionnaires

## Key facts

- **NCT ID:** NCT00354003
- **Lead sponsor:** Institute for Neurodegenerative Disorders
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2008-06-27
- **Final completion:** 2008-08
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2019-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00354003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00354003, "The Study of the Impact of Disclosing Imaging Study Information to Trial Participants". Retrieved via AI Analytics 2026-09-22 from https://api.ai-analytics.org/clinical/NCT00354003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*